Whiteoak Capital Pharma And Healthcare Fund Regular-growth
Latest AUM
₹ 556.4 Cr.
NAV as on 29 may, 2026
₹ 14.96
Fund Details
Portfolio Composition Analysis
Sector Allocations
Portfolio Updated on: 29 may, 2026
Top 10 Holdings
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 12.35% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 11.85% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 1.00% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 10.91% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 10.72% |
| JB Chemicals & Pharmaceuticals Ltd | Healthcare | Equity | 9.44% |
| JB Chemicals & Pharmaceuticals Ltd | Healthcare | Equity | 8.90% |
| JB Chemicals & Pharmaceuticals Ltd | Healthcare | Equity | 9.11% |
| JB Chemicals & Pharmaceuticals Ltd | Healthcare | Equity | 8.38% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 8.31% |
Debt & Credit Risk Analysis
Returns Analysis
| Tenure | Absolute | Annualised | Category Average |
|---|---|---|---|
| 3 Months | 7.00% | NA | 6.12% |
| 6 Months | 5.63% | NA | 12.92% |
| 9 Months | 8.05% | NA | 4.47% |
| 1 Year | 14.73% | 14.73% | 6.04% |
| 2 Years | 49.11% | 22.11% | 24.93% |
Whiteoak Capital Pharma And Healthcare Fund Regular-growth is one Equity mutual fund offered by WhiteOak Capital Mutual Fund. Launched on 06 Feb 2024, the fund aims Long term capital appreciation. Investment predominantly in equity & equity related instruments of Pharma and Healthcare companies. It manages assets worth ₹556.4 crore as on Tue Mar 31, 2026. The expense ratio stands at 2.17%.
Trupti Agrawal has experience Prior to joining WhiteOak Capital Mutual Fund, she has worked with L&T Infrastructure Finance Co. Ltd. and Ernst & Young.
Ashish Agrawal has experience Prior to joining Whiteoak Capital AMC, he was working with Motilal Owal Asset Management Co. Ltd from 2016 till date. Citigroup Global Markets Ltd from 2010 to 2016
Piyush Baranwal has experience Prior to joining WhiteOak Capital Mutual Fund he has worked with BOI AXA, Morgan Stanley Investment Management (Jan, 2011-June, 2014) and Principal Pnb AMC as a Dealer- Fixed Income (May, 2008-Jan, 2011).
Ramesh Mantri has experience Prior to joining WhiteOak Capital Mutual Fund, he has worked with WhiteOak Capital Management, Ashoka Capital Advisers, Smith Management, and CRISIL.
Dheeresh Pathak has experience Prior to joining WhiteOak Capital Mutual Fund, he has worked with Goldman Sachs
Top Performing Mutual Funds
growth is based on 1-month returns of the funds & Top fund are based on 3Y Returns
More Funds from WhiteOak Capital Mutual Fund
| Fund name | |||||||
|---|---|---|---|---|---|---|---|
| Whiteoak Capital Pharma And Healthcare Fund Direct-growth | 556.4 | +4.99% | +7.46% | +6.54% | +16.70% | — | — |
growth is based on 1-month returns of the funds
Top Mutual Funds
| Fund name | |||||||
|---|---|---|---|---|---|---|---|
| Nippon India Pharma Fund Direct-growth | 7,898.2 | +2.37% | +2.91% | +2.90% | +5.82% | +22.93% | +13.62% |
| Nippon India Pharma Fund-growth | 7,898.2 | +2.29% | +2.68% | +2.45% | +4.88% | +21.84% | +12.60% |
| Nippon India Pharma Fund-idcw | 7,898.2 | +2.29% | +2.68% | +2.45% | +4.88% | +21.84% | +12.60% |
| Nippon India Pharma Fund Direct-idcw | 7,898.2 | +2.37% | +2.91% | +2.90% | +5.82% | +22.93% | +13.62% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth | 6,293.1 | +2.58% | +6.59% | +2.18% | +7.19% | +27.68% | +16.50% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-growth | 6,293.1 | +2.53% | +6.38% | +1.79% | +6.32% | +26.62% | +15.49% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw | 6,293.1 | +2.58% | +6.59% | +2.18% | +7.19% | +27.68% | +16.50% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw | 6,293.1 | +2.53% | +6.38% | +1.79% | +6.32% | +26.62% | +15.49% |
| SBI Healthcare Opportunities Fund-growth | 4,063.6 | +4.56% | +6.46% | +5.11% | +9.86% | +24.70% | +15.48% |
| SBI Healthcare Opportunities Fund Direct Plan-growth | 4,063.6 | +4.65% | +6.73% | +5.64% | +10.98% | +26.01% | +16.71% |
Top funds are based on Fund AUM
Top Equity Funds
| Fund name | ||||
|---|---|---|---|---|
| Sbi Healthcare Opportunities Fund Direct Plan-growth | ₹530.58 | +26.01% | +16.71% | — |
| Sbi Healthcare Opportunities Fund Direct Plan-idcw | ₹368.63 | +26.01% | +16.71% | — |
| Icici Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth | ₹44.93 | +27.68% | +16.50% | — |
| Icici Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw | ₹27.14 | +27.68% | +16.50% | — |
| Dsp Healthcare Fund Direct-growth | ₹45.57 | +24.25% | +15.96% | — |
| Dsp Healthcare Fund Direct-idcw | ₹26.35 | +24.25% | +15.96% | — |
| Mirae Asset Healthcare Fund Direct-growth | ₹47.19 | +26.14% | +15.83% | — |
| Mirae Asset Healthcare Fund Direct-idcw | ₹28.42 | +26.14% | +15.83% | — |
| Icici Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-growth | ₹41.41 | +26.62% | +15.49% | — |
| Icici Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw | ₹24.16 | +26.62% | +15.49% | — |
growth is based on 5Y returns of the funds
Historical NAV
| Date | NAV |
|---|---|
| 29 May 2026 | ₹14.96 |
| 27 May 2026 | ₹15.07 |
| 25 May 2026 | ₹15.12 |
| 22 May 2026 | ₹15.04 |
| 21 May 2026 | ₹15.22 |
| 20 May 2026 | ₹15.14 |
| 19 May 2026 | ₹15.13 |
| 18 May 2026 | ₹15.03 |
| 15 May 2026 | ₹15.01 |
| 14 May 2026 | ₹15.00 |
| 13 May 2026 | ₹14.80 |
| 12 May 2026 | ₹14.77 |
| 11 May 2026 | ₹15.07 |
| 08 May 2026 | ₹14.93 |
| 07 May 2026 | ₹14.83 |
| 06 May 2026 | ₹14.78 |
| 05 May 2026 | ₹14.51 |
| 04 May 2026 | ₹14.49 |
| 30 Apr 2026 | ₹14.22 |
| 29 Apr 2026 | ₹14.22 |
| 28 Apr 2026 | ₹14.15 |
| 27 Apr 2026 | ₹14.23 |
| 24 Apr 2026 | ₹13.90 |
| 23 Apr 2026 | ₹14.03 |
| 22 Apr 2026 | ₹13.89 |
| 21 Apr 2026 | ₹13.85 |
| 20 Apr 2026 | ₹13.85 |
| 17 Apr 2026 | ₹13.87 |
| 16 Apr 2026 | ₹13.81 |
| 15 Apr 2026 | ₹13.81 |
Portfolio Updated on: 30 May, 2026
Fund Growth & Size Analysis
Compare Mutual funds
Whiteoak Capital Pharma And Healthcare Fund Regular-growth Returns Comparison
Compare Whiteoak Capital Pharma And Healthcare Fund Regular-growth with any MF,
EYF, stock or index
No funds found for your search.
